Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$2.39
0.041.70%
Pre-Market: Apr 4, 9:21 AM EDT
Comments
Loading...
Kodiak Sciences Analyst Ratings and Price Targets | NASDAQ:KOD | Benzinga
Kodiak Sciences Inc has a consensus price target of $8 based on the ratings of 12 analysts. The high is $20 issued by Jefferies on December 9, 2024. The low is $2 issued by Goldman Sachs on December 11, 2023. The 3 most-recent analyst ratings were released by HC Wainwright & Co., Jefferies, and Barclays on March 31, 2025, December 9, 2024, and November 15, 2024, respectively. With an average price target of $9 between HC Wainwright & Co., Jefferies, and Barclays, there's an implied 276.57% upside for Kodiak Sciences Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Jefferies
Barclays
UBS
Goldman Sachs
1calculated from analyst ratings
Analyst Ratings for Kodiak Sciences
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 03/31/2025 | Buy Now | 25.52% | HC Wainwright & Co. | Matthew Caufield37% | $3 → $3 | Reiterates | Neutral → Neutral | Get Alert |
| 12/09/2024 | Buy Now | 736.82% | Jefferies | Michael Yee55% | → $20 | Upgrade | Hold → Buy | Get Alert |
| 11/15/2024 | Buy Now | 67.36% | Barclays | Gena Wang50% | $3 → $4 | Maintains | Underweight | Get Alert |
| 11/15/2024 | Buy Now | 25.52% | HC Wainwright & Co. | Matthew Caufield37% | $3 → $3 | Reiterates | Neutral → Neutral | Get Alert |
| 09/24/2024 | Buy Now | 25.52% | HC Wainwright & Co. | Matthew Caufield37% | $3 → $3 | Reiterates | Neutral → Neutral | Get Alert |
| 09/05/2024 | Buy Now | 25.52% | HC Wainwright & Co. | Matthew Caufield37% | → $3 | Initiates | → Neutral | Get Alert |
| 04/04/2024 | Buy Now | 109.21% | UBS | Eliana Merle43% | $3 → $5 | Maintains | Neutral | Get Alert |
| 04/01/2024 | Buy Now | 25.52% | Barclays | Gena Wang50% | $2 → $3 | Maintains | Underweight | Get Alert |
| 12/21/2023 | Buy Now | 25.52% | UBS | Eliana Merle43% | $4 → $3 | Maintains | Neutral | Get Alert |
| 12/11/2023 | Buy Now | -16.32% | Goldman Sachs | Andrea Tan40% | → $2 | Reinstates | → Sell | Get Alert |
| 11/17/2023 | Buy Now | — | Capital One | Zegbeh Jallah65% | — | Upgrade | Equal-Weight → Overweight | Get Alert |
| 07/27/2023 | Buy Now | 67.36% | UBS | Eliana Merle43% | $15 → $4 | Downgrade | Buy → Neutral | Get Alert |
| 07/25/2023 | Buy Now | — | Chardan Capital | Daniil Gataulin40% | — | Downgrade | Buy → Neutral | Get Alert |
| 07/25/2023 | Buy Now | -16.32% | Barclays | Gena Wang50% | $5 → $2 | Maintains | Underweight | Get Alert |
| 07/25/2023 | Buy Now | — | JP Morgan | Anupam Rama57% | — | Downgrade | Neutral → Underweight | Get Alert |
| 07/24/2023 | Buy Now | 25.52% | Jefferies | Michael Yee55% | → $3 | Downgrade | Buy → Hold | Get Alert |
| 07/24/2023 | Buy Now | 192.89% | Capital One | Zegbeh Jallah65% | → $7 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 04/04/2023 | Buy Now | 318.41% | JP Morgan | Anupam Rama57% | $12 → $10 | Maintains | Neutral | Get Alert |
| 11/14/2022 | Buy Now | 276.57% | Morgan Stanley | Matthew Harrison61% | $12 → $9 | Maintains | Equal-Weight | Get Alert |
| 11/10/2022 | Buy Now | 234.73% | Goldman Sachs | Graig Suvannavejh54% | $9 → $8 | Maintains | Neutral | Get Alert |
| 08/15/2022 | Buy Now | 402.09% | Morgan Stanley | Matthew Harrison61% | $10 → $12 | Maintains | Equal-Weight | Get Alert |
| 08/10/2022 | Buy Now | 653.14% | Chardan Capital | Daniil Gataulin40% | $19 → $18 | Maintains | Buy | Get Alert |
| 08/09/2022 | Buy Now | 527.62% | Truist Securities | Robyn Karnauskas55% | $10 → $15 | Maintains | Buy | Get Alert |
| 08/09/2022 | Buy Now | 276.57% | Goldman Sachs | Graig Suvannavejh54% | $5 → $9 | Maintains | Neutral | Get Alert |
| 08/02/2022 | Buy Now | 151.05% | Citigroup | Neena Bitritto-Garg59% | → $6 | Downgrade | Neutral → Sell | Get Alert |
| 05/24/2022 | Buy Now | 109.21% | Goldman Sachs | Graig Suvannavejh54% | $7 → $5 | Maintains | Neutral | Get Alert |
| 05/17/2022 | Buy Now | 318.41% | Morgan Stanley | Matthew Harrison61% | $12 → $10 | Maintains | Equal-Weight | Get Alert |
| 05/11/2022 | Buy Now | 192.89% | Goldman Sachs | Graig Suvannavejh54% | $8 → $7 | Maintains | Neutral | Get Alert |
| 04/12/2022 | Buy Now | 402.09% | Morgan Stanley | Matthew Harrison61% | $17 → $12 | Maintains | Equal-Weight | Get Alert |
FAQ
What is the target price for Kodiak Sciences (KOD) stock?
The latest price target for Kodiak Sciences (NASDAQ:KOD) was reported by HC Wainwright & Co. on March 31, 2025. The analyst firm set a price target for $3.00 expecting KOD to rise to within 12 months (a possible 25.52% upside). 6 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Kodiak Sciences (KOD)?
The latest analyst rating for Kodiak Sciences (NASDAQ:KOD) was provided by HC Wainwright & Co., and Kodiak Sciences reiterated their neutral rating.
When was the last upgrade for Kodiak Sciences (KOD)?
The last upgrade for Kodiak Sciences Inc happened on December 9, 2024 when Jefferies raised their price target to $20. Jefferies previously had a hold for Kodiak Sciences Inc.
When was the last downgrade for Kodiak Sciences (KOD)?
The last downgrade for Kodiak Sciences Inc happened on July 27, 2023 when UBS changed their price target from $15 to $4 for Kodiak Sciences Inc.
When is the next analyst rating going to be posted or updated for Kodiak Sciences (KOD)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Kodiak Sciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Kodiak Sciences was filed on March 31, 2025 so you should expect the next rating to be made available sometime around March 31, 2026.
Is the Analyst Rating Kodiak Sciences (KOD) correct?
While ratings are subjective and will change, the latest Kodiak Sciences (KOD) rating was a reiterated with a price target of $3.00 to $3.00. The current price Kodiak Sciences (KOD) is trading at is $2.39, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.